Anti-CRMP5 Ab is usually associated with small cell lung cancer, paraneoplastic neurological syndrome and thymoma, manifesting with different disorders of the central and peripheral nervous systems. This evidence concerns the gene DPYSL5 and paraneoplastic neurologic syndrome.